Parham Diba

  • Current Program Year: Grad 3
  • M.D./Ph.D. Program Students, School of Medicine
  • Graduate Program in Biomedical Sciences Students, School of Medicine

Biography

Research interests: Cancer-Cachexia, Cardiac Remodeling, Cardioimmunology, Cardio-oncology, Sympathetic signaling

Education and training

  • Degrees

    • B.S., 2015, University of Oregon

Additional information

Honors and awards

  • OHSU N.L. Tartar Trust Fellowship, 2024
  • NHLBI F30 Ruth L. Kirschstein Predoctoral Fellowship Award, 2023
  • SCWD Young Investigator Award, 2023
  • OHSU N.L. Tartar Trust Fellowship, 2023
  • OHSU Research Week Best Poster, 2023
  • OSLER TL1 Predoctoral Fellowship, 2023
  • OHSU N.L. Tartar Trust Fellowship, 2022
  • OHSU Brenden-Colson Scientific Retreat Second Prize for Best Poster, 2022
  • Oregon American College of Physicians, 2nd place for Best Poster, 2022
  • OHSU Medical Scientist Training Program T32, 2019-2021

Publications

Selected publications

  • Diba P, Sattler AL, Korzun T, Habecker BA, Marks DL. Unraveling the lost balance: Adrenergic dysfunction in cancer cachexia, Autonomic Neuroscience: Basic and Clinical (2023), https://doi.org/10.1016/j.autneu.2023.103136
  • Korzun T. Moses AS, Diba P, Sattler AL, Taratula OR, Sahay G, Taratula O, Marks DL. From bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics. Pharmaceuticals 16, 2023, doi: 10.3390/ph16081088.
  • Korzun T, Moses AS, Diba P, Sattler AL, Olson B, Taratula OR, Pejovic T, Marks DL, Taratula O. Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gyenological Cancers. Small. 2023 Jul 30:e2301776. doi: 10.1002/smll.20231776. PMID: 37518857
  • Korzun T, Moses AS, Kin J, Patel S, Schumann C, Levasseur PR, Diba P, Olson B, Rebola KGO, Norgard M, Park Y, Demessie AA, Eygeris Y, Grigoriev V, Sundaram S, Pejovic T, Brody JR, Taratula OR, Zhu X, Sahay G, Marks DL, Tararula O. Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia. Small. 2022 Nov;18(44):e2204436. doi: 10.1002/smll.202204436.Epub 2022 Sep 13. PubMed PMID: 36098251.
  • Olson B, Zhu X, Norgard MA, Diba P, Levasseur PR, Buenafe AC, Huisman C, Burfeind KG, Michaelis KA, Kong G, Braun T, Marks DL. Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment. Brain Bhav Immun. 2021 OCT;97:102-118. doi: 10.1016/J.BBI.2021.07.002. Epub 2021 Jul 8. PubMed PMID: 34245812.
  • Olson B, Diba P, Korzun T, Marks DL. Neural Mechanisms of Cancer Cachexia. Cancers (Basel). 2021 Aug 7;13(16). doi: 10.3390/cancers13163990. Review. PubMed PMID: 34439145.
  • Ganz J, Melancon E, Wilson C, Amores A, Batzel P, Strader M, Braasch I, Diba P, Kuhlman JA, Postlethwait JH, Eisen JS. Epigenetic factors Dnmt1 and Uhrf1 coordinate intestinal development. Dev Biol. 2019 Nov 15;455(2):473-484. doi: 10.1016/j.ydbio.2019.08.002. Epub 2019 Aug 5. PubMed PMID: 31394080.
  • Spiewak JE, Bain EJ, Liu J, Kou K, Sturiale SL, Patterson LB, Diba P, Eisen JS, Braasch I, Ganz J, Parichy DM. Evolution of Endotheling signaling and diversification of adult pigment pattern in Danio fishes. PLoS Genet. 2018 Sep;14(9):e1007538. doi: 10.1371/journal.pgen.1007538. eCollection 2018 Sep. PubMed PMID: 30226839.
  • Ganz J, Baker RP, Hamilton MK, Melancon E, Diba P, Eisen JS, Parthasarathy R. Image velocimetry and spectral analysis enable quantitative characterization of larval zebrafish gut motility. Neurogastroenterol Motil. 2018 Sep;30(9):e13351. doi: 10.1111/nmo.13351. Epub 2018 May 2. PubMed PMID: 29722095.
  • Srivastava T, Diba P, Dean JM, Banine F, Shaver D, Hagen M, Gong X, Su W, Emery B, Marks DL, Harris EN, Baggenstoss B, Weigel PH, Sherman LS, Back SA. ATLR/AKT/FoxO3 immune tolerance-like pathway disrupts the repair capacity of oligodendrocyte progenitors. J Clin Invest. 2018 May 1;128(5):2025-2041. doi: 10.1172/JCI94158. Epub 2018 Apr 16. PubMed PMID: 29664021.

Publications